PHARMAMEDRX, LLC – Trademark Portfolio

Entity Type: 16

PHARMAMEDRX, LLC holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 44 (Medical Services) — 2 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include MINT RX. The owner is based in NORTH PALM BEACH, FL.

1201 US HIGHWAY 1

SUITE 305

NORTH PALM BEACH, FL 33408

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

MINT RX
MINT RX
Registered 2018
MINT RX
MINT RX
Registered 2018

Trademark Classifications

PHARMAMEDRX, LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

44
Medical Services (2 filings)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

5
Pharmaceuticals (2 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does PHARMAMEDRX, LLC have?

PHARMAMEDRX, LLC has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does PHARMAMEDRX, LLC file in?

PHARMAMEDRX, LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 44 (Medical Services), Class 5 (Pharmaceuticals). Class 44 covers medical services; veterinary services; hygienic and beauty care for human beings or animals.

What are PHARMAMEDRX, LLC's most well-known trademarks?

PHARMAMEDRX, LLC's registered trademark portfolio includes well-known marks such as MINT RX. These are among 2 currently registered trademarks in the portfolio.

What is PHARMAMEDRX, LLC's trademark registration success rate?

PHARMAMEDRX, LLC has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.